Clinical Trials
Last Updated: 1/23/09
Untreated
- Indolent Lymphoma
- Intermediate/High Grade Lymphoma
- Hodgkin's Lymphoma
- Mantle Cell Lymphoma
- Peripheral T-Cell Lymphoma
- Multiple Myeloma
Prior Treated
- Indolent Lymphoma
- Intermediate Grade Lymphoma
- Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Peripheral T-Cell Lymphoma
- Multiple Myeloma
- Phase I Agents
Supportive Care
Previous Post-Allo Transplant
Untreated
Indolent Lymphoma
- Lenalidomide, Rituximab (2008-0042)
- Zevalin (2005-0512)
- R-FND + Zevalin (ID03-0287)
- Rituximab + Sargramostim (2006-0260)
Intermediate/High Grade Lymphoma
- R-CHOP + Doxorubicin (2004-0305)
- R-HCVAD alternating with /R-Methotrexate-Cytarabine vs R-CHOP (2005-0054)
- Enzastaurin maintenance post R-CHOP (2006-0207)
- Enzastaurin (2008-0125)
Hodgkin's Lymphoma
- RABVD (2007-0144)
Mantle Cell Lymphoma
- Bortezomib + R-HyperCVAD alternating with Bortezomib+ R-High dose Methotrexate/Cytarabine (2006-0697)
Peripheral T-Cell Lymphoma
Multiple Myeloma/Waldenstrom’s
- Bortezomib + Rituximab (2005-0733)
Prior Treatment
Indolent Lymphoma
- Rituxan + GM-CSF (2006-0313)
- CMC-544 + Rituximab (2006-0415)
- Hu-Max-CD20 (2006-0645)
- SAR3419 (2006-1092)
- MGCD0103 + Azacitidine (2007-0536)
- AMG 655 + Bortezomib or Vorinostat (2007-0906)
- Milatuzumab (2008-0075)
- SB1518 (2008-0105)
- Velcade + Bendamustine and Rituximab (2008-0124)
Intermediate Grade Lymphoma
- Depsipeptide (2005-0579)
- CMC-544 + Rituximab (2006-0415)
- CCI-779 (2004-0612)
- YM155 (2007-0229) ON HOLD
- R-ICE +/- SGN40 (2007-0578)
- SAR3419 (2006-1092)
- CC-5013 + Rituxan (2005-0461)
- SB1518 (2008-0105)
- AMG 655 +Bortezomib or Vorinostat (2007-0906)
- MLN 8237 (2008-0278)
- Milatuzumab (2008-0075)
Hodgkin's Lymphoma
- SGN 35 (2008-0639)
- SGN-35 +/- Gemcitabine (2008-0001)
- SB1518 (2008-0105)
- 17-AAG (2004-0792)
- XmAb2513 (2007-0796)
- Panobinostat (2008-0401)
- HCD 122 (2008-0062)
- AMG 655 + Bortezomib or Vorinostat (2007-0906)
Mantle Cell Lymphoma
- SB1518 (2008-0105)
- CC-5013 + Rituxan (2005-0461)
- 17-AAG (2004-0792)
- Depsipeptide (2005-0579)
- SAR3419 (2006-1092)
- MLN8237 (2008-0278)
- AMG 655 + Bortezomib or Vorinostat (2007-0906)
- Milatuzumab (2008-0075)
Peripheral T-cell Lymphoma
- SB1518 (2008-0105)
- Romidepsin (Depsipeptide, FK228) (2006-0986)
- SGN-35 vs SGN-35 + Gemcitabine (2008-0001)
- 17-AAG (2004-0792)
- XmAb2513 (2007-0796)
Multiple Myeloma/Waldenstrom's
- SAHA + Bortezomib (2005-0438)
- CNTO 328 (2007-0479)
- Carfilzomib (2007-0398)
- Carfilzomib (2007-0399)
- CNTO 328 + Velcade vs Velcade (2007-0716)
Phase I Agents
- AMG 655 + Bortezomib or Vorinostat (2007-0906)
- Apo2L/TRAIL + Rituxan (2006-0258)
- CC-5013 + Rituxan (2005-0461)
- Milatuzumab (2008-0075)
- SB1518 (2008-0105)
- XmAb2513 (2007-0796)
- MLN8237 (2008-0278)
- HCD 122 (2008-0062)
Supportive Care
- Zometa (2005-0698)